ProHealth health Vitamin and Natural Supplement Store and Health
Home  |  Log In  |  My Account  |  View Cart  View Your ProHealth Vitamin and Supplement Shopping Cart
800-366-6056  |  Contact Us  |  Help
Facebook Google Plus
Fibromyalgia  Chronic Fatigue Syndrome & M.E.  Lyme Disease  Natural Wellness  Supplement News  Forums  Our Story
Store     Brands   |   A-Z Index   |   Best Sellers   |   New Products   |   Deals & Specials   |   Under $10   |   SmartSavings Club

Trending News

Is Magnesium the Missing Link in Your Heart Healthy Routine?

A Little Zinc Goes a Long Way

Supplementation with vitamin D associated with improved testosterone, erectile function among middle...

More evidence for calorie restriction’s longevity effect

Vitamin D deficiency increases risk of chronic headache

Wearable biosensors can flag illness, Lyme disease, risk for diabetes; low airplane oxygen

VIDEO: The Best Brain Foods That Help Increase Your Memory!

Iron (And More) For Lasting, Natural Energy

Affordable Care Act made cancer screening more accessible for millions, study finds

Metabolic syndrome increases the need for vitamin E

 
Print Page
Email Article

New study proves steroids are not the answer to halting Alzheimer progress

  [ 25 votes ]   [ Discuss This Article ]
www.ProHealth.com • February 7, 2000


A new study extinguishes hopes that low dose steroid therapy halts the progression of Alzheimer’s disease. In a study conducted at Georgetown University Medical Center in Washington, D. C. researchers investigated the possibility that steroid treatment could offer protection against the ravages of Alzheimer’s.

Inflammation in the brain has been correlated with the downward spiral that accompanies Alzheimer’s. Lead author Dr. Paul S. Aisen and colleagues recruited, treated with either low-dose prednisone or a placebo, and compared results in 138 Alzheimer’s patients. Prendisone is an adrenocorticoid used for its anti-inflammatory and immunosuppressive effect in the treatment of an array of medical problems including cancer. Patients given low-dose prednisone started with 20 milligrams daily for one month, followed by 10 milligrams daily for one year. A gradual reduction over a four-month period concluded the study.

Results were far from promising, after treatment concluded mental function among the placebo group and the steroid group appeared to be virtually identical. In fact, participants treated with the prednisone experienced more behavioral problems than those in the placebo group.

Aisen pointed out that, “the low dose of prednisone is not helpful. It may have been too low a dose to influence the inflammatory mechanism in the brain.” However, the notion of increasing the dose is not meet with enthusiasm, it may prove to protect against the deterioration of mental function those with Alzheimer’s experience yet the side effects would most likely outweigh the benefits. Common side effects include indigestion, vomiting, headache, insomnia, weight gain and poor wound healing. Mood or emotional changes occur in some individuals and have a negative impact upon behavior.

Aisen reported that his next step consists of undergoing the same research using a different family of medications known as nonsteroidal anti-inflammatory drugs (NSAIDs) which are used to treat pain, fever, and inflammation. The study is going to focus on comparing two NSAIDs; non-prescription drug naproxen (Aleve) and prescription drug rofecoxib (Vioxx) to a placebo. Aisen anticipates that the study results will be available in 2 to 3 years.

These drugs may be able to succeed where steroids failed since they battle cyclooxygenase, an enzyme that is hypothesized to contribute to Alzheimer’s. Dr. Ian R.A. Mackenzie, of the University of British Colombia in Canada, conducted a study that is published in the same issue of Neurology as Aisen’s, and concluded from his results that NSAIDs are more effective than steroids at reducing the brain inflammation found in Alzheimer patients. The side effects from NSAID use are considerably more mild than those associated with steroid use. Possible adverse reactions consist of dizziness, stomach cramps, nausea, and headaches.



Post a Comment

Featured Products From the ProHealth Store
Optimized Curcumin Longvida® Vitamin D3 Extreme™ Ultra EPA  - Fish Oil

Looking for Vitamins, Herbs and Supplements?
Search the ProHealth Store for Hundreds of Natural Health Products


Article Comments



Be the first to comment on this article!

Post a Comment


 
NAD+ Ignite with Niagen

Featured Products

Ultra ATP+, Double Strength Ultra ATP+, Double Strength
Get energized with malic acid & magnesium
Energy NADH™ 12.5mg Energy NADH™ 12.5mg
Improve Energy & Cognitive Function
Mitochondria Ignite™ with NT Factor® Mitochondria Ignite™ with NT Factor®
Reduce Fatigue up to 45%
Ultra EPA  - Fish Oil Ultra EPA - Fish Oil
Ultra concentrated source of essential fish oils
FibroSleep™ FibroSleep™
The All-in-One Natural Sleep Aid

Natural Remedies

Breaking Through the Mental Fog Breaking Through the Mental Fog
More Weight Loss than Any Other Discovery in Supplement History More Weight Loss than Any Other Discovery in Supplement History
Strontium - The Missing Mineral for Strong Bones Strontium - The Missing Mineral for Strong Bones
Guarding Against the Dangers of Vitamin D Deficiency Guarding Against the Dangers of Vitamin D Deficiency
Fatigue & Fibro Fog: Could You Have a B-12 Deficiency? Fatigue & Fibro Fog: Could You Have a B-12 Deficiency?

CONTACT US
ProHealth, Inc.
555 Maple Ave
Carpinteria, CA 93013
(800) 366-6056  |  Email

· Become a Wholesaler
· Vendor Inquiries
· Affiliate Program
SHOP WITH CONFIDENCE
Credit Card Processing
SUBSCRIBE TO OUR NEWSLETTERS
Get the latest news about Fibromyalgia, M.E/Chronic Fatigue Syndrome, Lyme Disease and Natural Wellness

CONNECT WITH US ProHealth on Facebook  ProHealth on Twitter  ProHealth on Pinterest  ProHealth on Google Plus

© 2017 ProHealth, Inc. All rights reserved. Pain Tracker App  |  Store  |  Customer Service  |  Guarantee  |  Privacy  |  Contact Us  |  Library  |  RSS  |  Site Map